More on AVLN
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $24.64 |
|
|||
| Open | $24.72 | ||||
| 52 Wk High | $0.00 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $24.72 | ||||
| Day Low | $23.53 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 291,443 | ||||
- Raymond James Starts Avalyn Pharma (AVLN) at Outperform
- Form 4 Avalyn Pharma Inc. For: Sep 15 Filed by: Meyer Robert J.
- Form 3 Avalyn Pharma Inc. For: Sep 15 Filed by: Meyer Robert J.
- Form 8-K Avalyn Pharma Inc. For: Sep 15
- Avalyn Pharma adds ex-FDA official Robert Meyer to its board
- Avalyn Appoints Robert J. Meyer, MD, to its Board of Directors
- Avalyn Pharma presents AP01 lung distribution data at ERS 2026
- Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis
- Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
- Avalyn Announces Multiple Presentations at the European Respiratory Society International Congress 2026
Entities mentioned with AVLN
- IPO | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Jefferies & Co | View Related Stories »
- Morgan Stanley | View Related Stories »
- Guggenheim | View Related Stories »
- 13G | View Related Stories »
- Show More...
